Pharmaceutical Expertise. Regulatory Rigour. Evidence-Based Review.

Dr. Jürgen Epple is a German pharmaceutical and regulatory affairs professional with extensive experience in scientific communication, medical information, and regulatory strategy within the pharmaceutical industry. Based in Bavaria, Germany, he has worked in senior roles supporting the development, approval, and lifecycle management of innovative pharmaceutical products.

Throughout his career, Dr. Epple has contributed to bridging the gap between scientific research, regulatory compliance, and clinical application, helping ensure that medicines meet stringent European and international regulatory standards. His work involves the interpretation of complex clinical data, preparation of regulatory documentation, and collaboration with multidisciplinary teams across research, medical, and commercial functions.

Dr. Epple has also been involved in medical information and scientific affairs, supporting healthcare professionals and stakeholders with evidence-based data on pharmaceutical products. In leadership roles within pharmaceutical organizations, he has helped guide regulatory strategy, oversee scientific communication, and contribute to the responsible introduction of therapies into the healthcare system.

With a background in scientific research and pharmaceutical development, Dr. Epple’s work reflects a strong commitment to advancing patient care through science, regulatory excellence, and transparent medical communication. As a medical reviewer for Sunny Pharma®, he brings this same standard of rigour to evaluating content on HIV antiretroviral therapy, generic pharmaceutical equivalence, and evidence-based treatment guidance.

Fields of Specialization

Dr. Epple’s professional practice spans the intersection of pharmaceutical science, regulatory strategy, and medical communication. His recognized areas of expertise include:

Review Standards & Editorial Transparency

All content reviewed by Dr. Jürgen Epple for Sunny Pharma® is evaluated against current WHO HIV treatment guidelines, DHHS Adult ARV Treatment Guidelines, European Medicines Agency (EMA) regulatory standards, and the latest peer-reviewed evidence in antiretroviral pharmacotherapy and pharmaceutical science. Dr. Epple applies the same standard of evidence interpretation he brings to his pharmaceutical industry work, ensuring every reviewed article is factually accurate, appropriately caveated, and suitable for a patient-facing audience.

Dr. Epple has no financial relationships with any antiretroviral pharmaceutical manufacturer in a capacity that would create a conflict of interest with his review role at Sunny Pharma®. His compensation is a fixed review fee, independent of all commercial outcomes on the platform.

Last credentials verified: March 2026  |  Editorial oversight: Stephanie Ritz, PhD, Medical Writer